Approval · Notice of Compliance 26616 · 2021
KANUMA: Notice of Compliance 26616
Issued September 8, 2021
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 26616
- Date
- September 8, 2021
- Company
- Alexion Pharma GmbhBaar, --, Switzerland
- Product type
- Biologic
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Admin
- Reason
- Fulfillment of commitments 2 II-III from the Letter of Undertaking dated November 22, 2017 issued under NDS control number 204085
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| KANUMA | Not yet assigned | — |
Medicinal ingredients
- SEBELIPASE ALFA 2 MG per ML